Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Current Opinion in Pharmacology|February 5, 2008
Implication of microRNAs in the cardiovascular systemElizabeth Scalbert, Antoine BrilCurrent Opinion in Pharmacology|January 29, 2008
Rho exchange factors in the cardiovascular systemGervaise Loirand, Elizabeth Scalbert, Antoine Bril, et al.Peptides|February 26, 2008
Behavioral actions of urotensin-IIJean-Claude do Rego, Jérôme Leprince, Elizabeth Scalbert, et al.British Journal of Pharmacology|August 2, 2003
Melatonin inhibits nitrate tolerance in isolated coronary arteriesStephen T O'Rourke, Hana Hammad, Philippe Delagrange, et al.British Journal of Pharmacology|January 14, 2004
Impact of treatment with melatonin on cerebral circulation in old ratsFrançois Dupuis, Olivier Régrigny, Jeffrey Atkinson, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|April 10, 2003
Rho-kinase inhibitors: pharmacomodulations on the lead compound Y-32885Cédric Logé, Valérie Wallez, Elizabeth Scalbert, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|September 29, 2004
Design and synthesis of indole and tetrahydroisoquinoline hydantoin derivatives as human chymase inhibitorsDavid Alagille, Bruno Pfeiffer, Elizabeth Scalbert, et al.Journal of Medicinal Chemistry|May 2, 2003
Synthesis and biological evaluation of new 2-(4,5-dihydro-1H-imidazol-2-yl)-3,4-dihydro-2H-1,4-benzoxazine derivativesFrédérique Touzeau, Axelle Arrault, Gérald Guillaumet, et al.Journal of Vascular Research|January 4, 2005
Stent implantation activates RhoA in human arteries: inhibitory effect of rapamycinPatrice Guérin, Vincent Sauzeau, Malvyne Rolli-Derkinderen, et al.Circulation|March 6, 2002
Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulationVéronique Bruban, Vanessa Estato, Stephan Schann, et al.Pageof 3